Social Service


As an important teaching, research and exchange base and a public platform for serving pharmaceutical companies in Guangxi's pharmacy and chemistry fields, the laboratory is not only open to teachers and students of relevant disciplines, but also to scientific research workers from Guangxi, the whole country and even abroad, including experts. Scholars and international students have visited and actively carried out extensive multilateral exchanges and cooperation. As an outstanding member of the large-scale instrument cooperation network in Guangxi, the laboratory currently has a total of 13 network instruments, each with a value of more than one million yuan, more than 300 external testing services, and a test income of nearly 50,000 yuan. The test service targets mainly include related enterprises and research institutes in the peripheral medicine and raw material production in Guilin.

1. Cooperation with enterprises in industry, academia and research

  In 2016, the laboratory continued to rely on its own platform of the Southwestern National Medicine Collaborative Center to strengthen cooperation with enterprises and provide the driving force for enterprise product research and development and technological innovation. Cooperated with pharmaceutical companies to carry out research projects such as secondary development of products and standard upgrades, among which Guilin Sanjin Pharmaceutical Corp cooperated with the project of “Research on the secondary development of the indications for the expansion of Yanhuanglian preparations”, and Guilin Nanfang Pharmaceutical Corp Cooperative "New Technology and Development of New Arthritis" project.

The laboratory uses its own platform and talent advantages to carry out cooperative research projects, provide technical support for the in-depth development of enterprise products, provide theoretical data for the internationalization of product standards, and make important progress. During the implementation of the project “Development of Green Pesticides Synergist with Rosin as Raw Material”, Professor Zhong Jiangke completed the pilot test of rosin preparation of green pesticide synergist on the pilot line of 15 tons of rosin. A total of 21 tons of rosin was processed in batches, with an added value of 1,588.5 thousand yuan, a tax of 267,900 yuan, and a net profit of 435,400 yuan, that is, a profit and tax of 703,300 yuan. The production trial of rosin green pesticide synergist was completed on the production line of about 200 tons of rosin. The new output value of the production line was 15.13 million yuan, the tax revenue was about 3.04 million yuan, and the net profit was about 4.94 million yuan.

In 2016, the laboratory research project was established for the first time, and the “Industry-University-Research Project” was established to strengthen the laboratory's actions for Guangxi pharmaceutical companies through cooperation with enterprises. A total of three production, research and research projects have been set up, including the research on the quality standard of Sanjin Tablet based on the comprehensive analysis of chemical composition of ointment in cooperation with Guilin Sanjin Pharmaceutical Corp, and the artemisinin in cooperation with Guilin Nanfang Corp The synthesis and anti-tumor activity of derivatives and its mechanism of action, and the technical research and development of products such as the combination of Camellia Saponin and Kaempferol with Guilin Rheinland Pharmaceutical Corp.

In 2017, the project was completed under the auspices of Professor Wang Hengshan and co-operated with Guilin Sanjin Pharmaceutical Corp, “Study on Separation and Identification of Main Chemical Components of Sanjin Tablet Extract and Preparation of Chemical Reference Materials for Content Determination”, from Sanjin Tablet Dipping The main chemical components were separated and identified in the paste, and qualitative and quantitative analysis systems were established. The transfer of project results was completed. In the follow-up work, the new standards for the formation of the National Pharmacopoeia will be improved, and the upgrading of the Sanjin film series and the improvement of the process technology will greatly promote the internationalization of the product. On the basis of the completion of the project, we continued to cooperate with Guilin Sanjin Pharmaceutical Corp to carry out research and development work on the horizontal project "Separation and identification of the main chemical components of Zhuangyao Yangyang opening and the purification of chemical reference materials for content determination".

In 2018, Professor Wang Hengshan and Guilin Sanjin Pharmaceutical Corp continued the joint research project "Study on the Separation and Identification of Main Chemical Components of Sanjin Tablet Extract and Purification Preparation of Chemical Reference Materials for Content Determination", and cooperated with Hainan Jianke Pharmaceutical Corp cooperated in the research and development of the project "Hainan coconut oil main ingredient identification and testing research".

2. Technology transfer

Professor Liu Yancheng's patent for the invention, monochlorobis (2-benzoylpyridine)platinum(II) and its synthesis method and application, was successfully transferred to Shanghai Lizhu Biotechnology Corp.

3. Industrialization of important results

The project "Development and Preclinical Research on Yao Medicine Copper Diamond Anti-inflammatory Products", which was presided over by Professor Pan Yingming and cooperated with the Research Institute of Guangxi Academy of Forestry and the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, completed the project. The inflammatory component was made into a pain-relieving patch in the form of a compound. It applied for 2 Chinese invention patents, and reached the scale of the pilot test and obtained the product registration. On this basis, the new product quality standard for pain-relieving paste was established, which has a good market expectation.